Origin of cholesterol in the fetal golden Syrian hamster: contribution of de novo sterol synthesis and maternal-derived lipoprotein cholesterol.
A fetal hamster increases in mass almost 100-fold in the third trimester of gestation. During this 5.5-day period, the acquisition of over 4 mg of cholesterol is required for normal development. The purpose of the present studies was to determine the potential source(s) of this fetal sterol. Rates of cholesterol synthesis in the whole fetus were measured initially. Synthesis rates in the whole fetus increased linearly from 10 days (approximately 25 nmol sterol/h) through 13.5 days of gestation (approximately 400 nmol sterol/h). During the last 1.5 days of intrauterine development, rates remained constant. Even though the synthesis rates were relatively elevated, as compared to those in an adult, the amount of cholesterol synthesized was about half of that accrued. When synthesis rates in all of the fetal tissues were summed, however, a majority of the sterol in the fetus could now be accounted for. During this same time when the fetus was accumulating 4 mg of cholesterol, the placenta and yolk sac increased in cholesterol content by 2.5 mg, indicating the need for a second source of sterol for fetal tissue development. Two other sources of sterol for these tissues were found to be maternal low density and high density lipoprotein (LDL and HDL, respectively). In fact, more than 0.9 mg of cholesterol was taken up during the third trimester as LDL. To summarize, a majority of cholesterol in the fetus could be accounted for by synthesis in all fetal tissues. Additionally, a significant amount of cholesterol was taken up as maternal-derived LDL and HDL by these same tissues.
Woollett
L A
LA
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8887, USA.
D000818:Animals; D002784:Cholesterol / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000378:metabolism*; D006224:Cricetinae; D005314:Embryonic and Fetal Development; D005260:Female; D005333:Fetus / Q000378:metabolism*; D005865:Gestational Age; D007700:Kinetics; D008431:Maternal-Fetal Exchange; D008647:Mesocricetus; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D013261:Sterols / Q000096:biosynthesis*; D014316:Tritium; D014599:Uterus / Q000378:metabolism; D015017:Yolk Sac / Q000378:metabolism
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D013261:Sterols; D014316:Tritium; D002784:Cholesterol